Physician profile
Beverly M Yee
NPI 1609866748
$3,536.62
in general payments reported to CMS, 2019-2025
36 companies · $453 in 2025
The $453 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $503 · 2021: $746 · 2022: $505 · 2023: $402 · 2024: $649 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,504.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $492.56 | 2020-2025 | Airsupra, Farxiga |
| Novo Nordisk INC | $333.38 | 2019-2024 | Rybelsus, Ozempic |
| Abbvie INC. | $306.32 | 2021-2024 | Vraylar, Ubrelvy, Qulipta |
| Takeda Pharmaceuticals U.S.A., INC. | $295.71 | 2020-2025 | Trintellix |
| Idorsia Pharmaceuticals US INC | $203.84 | 2022-2024 | Quviviq |
| Arbor Pharmaceuticals, INC. | $186.12 | 2019-2021 | |
| Lilly USA, LLC | $166.51 | 2022-2025 | Mounjaro, Zepbound, Kisunla |
| Antares Pharma, INC. | $151.81 | 2024-2025 | Xyosted |
| Eisai INC. | $144.87 | 2020-2022 | |
| Almatica Pharma LLC | $135.40 | 2024 | Loreev Xr, Teriparatide |
| Exact Sciences Corporation | $116.62 | 2024-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $111.63 | 2020-2021 | |
| Amgen INC. | $85.30 | 2020-2025 | Krystexxa |
| Endo Pharmaceuticals INC. | $69.04 | 2019-2020 | |
| Pfizer INC. | $68.26 | 2019-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $65.38 | 2019 | |
| Glaxosmithkline, LLC. | $59.72 | 2023 | Arexvy, Shingrix |
| Astellas Pharma US INC | $56.79 | 2023-2024 | Veozah |
| Allergan, INC. | $55.47 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $41.18 | 2021 | |
| Viiv Healthcare Company | $40.88 | 2023-2024 | Apretude |
| Tolmar, INC. | $40.73 | 2024 | |
| Esperion Therapeutics, INC. | $29.47 | 2020-2021 | |
| Daiichi Sankyo INC. | $28.75 | 2024 | Injectafer |
| Lucid Diagnostics INC. | $27.01 | 2022 | |
| Merck Sharp & Dohme LLC | $24.84 | 2020 | |
| Intra-Sana Laboratories | $23.56 | 2023 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Shield Therapeutics INC | $23.39 | 2022 | |
| Abbott Laboratories | $23.00 | 2024 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $22.59 | 2022 | |
| Acella Pharmaceuticals, LLC | $21.69 | 2025 | NP Thyroid 60 |
| Biohaven Pharmaceutical Holding Company LTD. | $18.43 | 2022 | |
| Acadia Pharmaceuticals INC | $18.18 | 2022 | |
| Gilead Sciences, INC. | $16.57 | 2019 | |
| Bardy Diagnostics, INC. | $15.95 | 2021 | |
| Adlon Therapeutics L.P. | $15.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Yee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.